PF-Atlas › Clinical Trials › NCT00880386

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Losartan · Not specified

Registry ID
NCT00880386
Phase
Not specified
Status
Withdrawn
Drug / intervention
Losartan
Sponsor
University of South Florida
Start
2009-03

About this trial

RATIONALE: Losartan potassium may be effective in treating pulmonary fibrosis caused by radiation therapy in patients with non-small cell lung cancer. PURPOSE: This clinical trial is studying losartan to see how well it works in treating pulmonary fibrosis caused by radiation therapy in patients with stage I, stage II, or stage III non-small cell lung cancer.

View NCT00880386 on ClinicalTrials.gov →

Explore related

All Losartan trialsAll IPF trials

Related trials

Losartan — NCT03435939losartan — NCT00879879
Medical disclaimer. This page summarizes public trial data for NCT00880386 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.